Kwality Pharmaceuticals Quarterly Results for Trading Insights
KPL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹14 Cr
QSept 2025
Kwality Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹112 Cr in Sept 2025 (-4.3% vs Mar 2025, +24.4% vs Sept 2024)
- Net Profit of ₹14 Cr in Sept 2025 (-6.7% vs Mar 2025, +55.6% vs Sept 2024)
- EBITDA of ₹26 Cr in Sept 2025 (-3.7% vs Mar 2025)
- Operating Margin of 23.0% in Sept 2025 (+1.0pp vs Mar 2025)
- Earnings Per Share of ₹13.60 in Sept 2025 (-2.5% vs Mar 2025)
Kwality Pharmaceuticals Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 112 | 117 | 112 | 124 | 90 | -4.3% | 24.4% |
| Net Profit (₹ Cr) | 14 | 15 | 12 | 16 | 9 | - | - |
| EBITDA (₹ Cr) | 26 | 27 | 25 | 30 | 20 | - | - |
| EPS (₹) | 13.60 | 13.95 | 11.49 | 15.42 | 8.15 | - | - |
| Operating Margin (%) | 23.0% | 22.0% | 22.0% | 24.0% | 22.0% | - | - |
Kwality Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Kwality Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.
Related Pages for Kwality Pharmaceuticals
Additional stock information and data for KPL
Revenue Trend (₹ Cr)
Dec 2025
124
Jun 2025
112
Mar 2025
117
Sept 2025
112
Net Profit Trend (₹ Cr)
Dec 2025
16
Jun 2025
12
Mar 2025
15
Sept 2025
14
Operating Margin Trend (%)
Dec 2025
24.0%
Jun 2025
22.0%
Mar 2025
22.0%
Sept 2025
23.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Kwality Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹430,344.72 Cr | 1693.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 130.3 |
|
Divis Laboratories
Sept 2025 |
₹159,214.78 Cr | 5856.5 | 2,860 | 689 | +7.1% | - | 24.1% | 225.5 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹144,367.29 Cr | 3987.2 | 3,219 | 591 | +11.3% | - | 18.4% | 227.3 |
|
Lupin
Sept 2025 |
₹107,238.09 Cr | 2274.5 | 6,921 | 1,485 | +23.2% | - | 21.5% | 70.3 |
|
Dr Reddys Laborator…
Sept 2025 |
₹106,974.57 Cr | 1217.3 | 9,135 | 1,337 | +1.1% | - | 14.6% | 75.2 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores